Alpha Teknova Inc 最大收入来源是 Lab Essentials,在最近的收益报告中收入为 28,800,000。就地区而言, United States 是 Alpha Teknova Inc 的主要市场,收入为 35,000,000。
Alpha Teknova Inc 是否盈利?
否,根据最新的财务报表,Alpha Teknova Inc 的净亏损为 $0
Alpha Teknova Inc 有负债吗?
否,Alpha Teknova Inc 的负债为 0
Alpha Teknova Inc 的流通股有多少?
Alpha Teknova Inc 的总流通股为 0
关键数据
前收盘价
$6.81
开盘价
$6.96
当日区间
$6.86 - $7.39
52周范围
$1.91 - $7.21
交易量
314.9K
平均成交量
154.7K
股息收益率
--
每股收益(TTM)
-0.32
市值
$386.5M
什么是 TKNO?
Alpha Teknova, Inc. engages in the manufacture of cell culture media and supplements. The company is headquartered in Hollister, California and currently employs 158 full-time employees. The company went IPO on 2021-06-25. The firm offers three primary product types: pre-poured media plates for cell growth and cloning; liquid microbial culture media and supplements for cellular expansion, and molecular biology reagents for sample manipulation, resuspension, and purification. The company offers a range of standard and specialty pre-poured media plates for a variety of applications including bacteria, fungi, and nematode growth. Its two primary product categories include Lab Essentials and Clinical Solutions. Its core Lab Essentials products consist of commonly used catalog solutions and customer-specified formulations. Its Clinical Solutions products are custom products used in the development and production of protein therapies, gene therapies, mRNA vaccines, and diagnostic kits.